Atlas Trials

A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)

Clinical trial NCT00168857 · COMPLETED

Trial details

NCT number
NCT00168857
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
HypertensionDiabetic Nephropathies
Start date
2003-07-09
Primary completion
2006-06-01
Enrollment
860

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.